Time to Initiation of the Second-Line Therapy Obeticholic Acid in Patients With Primary Biliary Cholangitis

被引：0
|
作者：
Kumar, Sonal [1 ]
Macewan, Joanna P. [2 ]
Levine, Alina [2 ]
Bessonova, Leona [3 ]
Nair, Radhika [3 ]
Wheeler, Darren [3 ]
Li, Jing [3 ]
Brown, Robert S. [1 ]
机构：
[1] Weill Cornell Med Coll, New York, NY USA
[2] Genesis Res Grp, Hoboken, NJ USA
[3] Intercept Pharmaceut Inc, Morristown, NJ USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词：
D O I：
10.14309/01.ajg.0001028872.30928.6d
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S126
引用
收藏
页码：S91 / S91
页数：1
相关论文
共 50 条
  • [21] Additive beneficial effects of Fibrates combined with Obeticholic acid in the treatment of patients with Primary Biliary Cholangitis and inadequate response to second-line therapy: data from the Italian PBC Study Group
    D'Amato, D.
    O'Donnell, S. E.
    Cazzagon, N.
    Marconi, G.
    Gerussi, A.
    Cristoferi, L.
    Malinverno, F.
    Mancuso, C.
    Milani, C.
    Marzioni, M.
    Floreani, A.
    Invernizzi, P.
    Carbone, M.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : E32 - E32
  • [22] A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis
    Kowdley, Kris V.
    Luketic, Velimir
    Chapman, Roger
    Hirschfield, Gideon M.
    Poupon, Raoul
    Schramm, Christoph
    Vincent, Catherine
    Rust, Christian
    Pares, Albert
    Mason, Andrew
    Marschall, Hanns-Ulrich
    Shapiro, David
    Adorini, Luciano
    Sciacca, Cathi
    Beecher-Jones, Tessa
    Boehm, Olaf
    Pencek, Richard
    Jones, David
    HEPATOLOGY, 2018, 67 (05) : 1890 - 1902
  • [23] EFFICACY OF OBETICHOLIC ACID TREATMENT IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS WITH CIRRHOSIS
    Vierling, J. M.
    Hirschfield, G.
    Jones, D. E.
    Groszmann, R.
    Kowdley, K. V.
    Pencek, R.
    Marmon, T.
    MacConell, L.
    GUT, 2017, 66 : A100 - A101
  • [24] Obeticholic acid normalizes inflammatory biomarkers in patients with primary biliary cholangitis
    Jones, David E.
    Bowlus, Christopher L.
    Thranian, Arash
    Erickson, Mary
    Li, Jing
    Gasink, Christopher
    Gish, Robert G.
    JOURNAL OF HEPATOLOGY, 2024, 80 : S325 - S325
  • [25] Treatment of Primary Biliary Cholangitis First-Line and Second-Line Therapies
    Liu, Chung-Heng
    Bowlus, Christopher L.
    CLINICS IN LIVER DISEASE, 2022, 26 (04) : 705 - 726
  • [26] Efficacy of Obeticholic Acid in Patients with Primary Biliary Cholangitis and Renal Impairment
    Pockros, Paul J.
    Reddy, K. Gautham
    Owens-Grillo, Janet
    Marmon, Tonya
    MacConell, Leigh
    HEPATOLOGY, 2016, 64 : 205A - 205A
  • [27] Efficacy of Obeticholic Acid Treatment in Patients with Primary Biliary Cholangitis with Cirrhosis
    Vierling, John M.
    Hirschfield, Gideon M.
    Jones, David
    Groszmann, Roberto J.
    Kowdley, Kris V.
    Pencek, Richard
    Marmon, Tonya
    MacConell, Leigh
    HEPATOLOGY, 2016, 64 : 187A - 187A
  • [28] Obeticholic Acid Normalizes Inflammatory Biomarkers in Patients With Primary Biliary Cholangitis
    Foston, Tenita
    Jones, David E.
    Bowlus, Christopher L.
    Thranian, Arash
    Erickson, Mary
    Li, Jing
    Gasink, Christopher
    Gish, Robert G.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S129 - S129
  • [29] Baseline Characteristics and Risk Profiles of 1111 Patients with Primary Biliary Cholangitis (PBC) in Need of Second-Line Therapy
    Hirschfield, Gideon
    Kowdley, Kris
    Kremer, Andreas
    Vierling, John
    Bowlus, Christopher
    Levy, Cynthia
    Mayo, Marlyn
    Crittenden, Daria
    Standen, Mary
    Yang, Ke
    Choi, Yun-Jung
    McWherter, Charles
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1171 - S1171
  • [30] Evolving role of obeticholic acid in primary biliary cholangitis
    Levy, Cynthia
    HEPATOLOGY, 2018, 67 (05) : 1666 - 1668
12345